EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Real‐World Characterization of Psychiatric Pharmacogenomic Test Ordering and Clinical Relevance in Adults and Children

Lusi Zhang iD, Anthony J Tholkes iD, Kaliya C Jones, Laylia J Yang iD, Gretchen K Sieger iD, Kathryn R Cullen iD, Meredith L Gunlicks-Stoessel iD, Pawel Mroz iD, Joel F Farley iD, Steven G Johnson iD, Jeffrey R Bishop iD

Clinical and Translational Science · 2025

DOI: 10.1111/cts.70297 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Lusi Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Pharmacogenomic Testing, Mental Disorders, Practice Patterns, Physicians', Psychotropic Drugs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, AAPP Foundation, University of Minnesota College of Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacogenomic (PGx) testing is increasingly utilized to guide psychiatric medication selection and dosing, yet real‐world characterizations of test ordering and clinical implications remain understudied. Additionally, the extent to which psychiatry‐focused PGx results inform prescribing beyond mental health medications is unclear. This study examined patterns of psychiatry‐focused PGx test ordering, the clinical relevance of results among adult and pediatric patients, and implementation challenges within a large health system. Electronic health records (EHRs) of 3383 individuals undergoing psychiatry‐focused PGx testing between 2013 and 2023 were analyzed. Test reports, available as unstructured PDFs, required manual curation before merging with clinical data. Demographic characteristics, test ordering patterns, genotype distributions, and drug‐gene interactions (DGIs) were assessed. Results indicated that 94.5% of individuals had one or more clinically actionable PGx variants. DGIs were identified for current psychiatric medications in 19.3% of adults and 15.0% of youth. Additionally, non‐psychiatric DGIs were identified in 11.8% of adults and 2.1% of youth. Most patients had genotype profiles that could guide future psychiatric and non‐psychiatric prescribing. Despite the clinical relevance, PGx results were inconsistently integrated into EHRs, limiting accessibility and reuse. Indicators of disparities in test ordering related to gender and race suggested systemic inequities and variability in provider adoption practices. Psychiatry‐focused PGx testing holds substantial potential to optimize current and future medication prescribing, extending beyond psychiatry. Key challenges include fragmented EHR integration, inconsistent provider adoption, and disparities in test ordering. Improved standardized reporting, structured EHR integration, and enhanced provider education are necessary to maximize PGx benefits in patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pharmacogenomic TestingMental DisordersPractice Patterns, Physicians'Psychotropic DrugsHumansAdultMaleFemaleChildElectronic Health RecordsAdolescentMiddle AgedYoung AdultAgedChild, PreschoolGenotypeClinical Relevance

Stichwörter der Autor:innen

PGxelectronic health recordmental healthpediatricspharmacogenomicsreal‐world evidence

Substanzen

Psychotropic Drugs

Autor:innen und Institutionen

  • Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
  • Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Psychiatry & Behavioral Sciences, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
  • Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
  • Department of Pharmaceutical Care & Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
  • Institute for Health Informatics, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID-Profile: Lusi Zhang, Anthony J Tholkes, Laylia J Yang, Gretchen K Sieger, Kathryn R Cullen, Meredith L Gunlicks-Stoessel, Pawel Mroz, Joel F Farley, Steven G Johnson, Jeffrey R Bishop

Förderung

  • NCATS NIH HHS
  • AAPP Foundation
  • University of Minnesota College of Pharmacy
  • National Center for Advancing Translational Sciences

Zitieren

APA

Zhang, L., Tholkes, A. J., Jones, K. C., Yang, L. J., Sieger, G. K., Cullen, K. R., Gunlicks-Stoessel, M. L., Mroz, P., Farley, J. F., Johnson, S. G., & Bishop, J. R. (2025). Real‐World Characterization of Psychiatric Pharmacogenomic Test Ordering and Clinical Relevance in Adults and Children. Clinical and Translational Science. https://doi.org/10.1111/cts.70297

Vancouver

Zhang L, Tholkes AJ, Jones KC, Yang LJ, Sieger GK, Cullen KR, et al. Real‐World Characterization of Psychiatric Pharmacogenomic Test Ordering and Clinical Relevance in Adults and Children. Clinical and Translational Science. 2025. doi:10.1111/cts.70297

BibTeX
@article{Zhang2025,
  author = {Zhang, Lusi and Tholkes, Anthony J and Jones, Kaliya C and Yang, Laylia J and Sieger, Gretchen K and Cullen, Kathryn R and Gunlicks-Stoessel, Meredith L and Mroz, Pawel and Farley, Joel F and Johnson, Steven G and Bishop, Jeffrey R},
  title = {Real‐World Characterization of Psychiatric Pharmacogenomic Test Ordering and Clinical Relevance in Adults and Children},
  journal = {Clinical and Translational Science},
  year = {2025},
  doi = {10.1111/cts.70297}
}
Kostenlos starten →